These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


291 related items for PubMed ID: 6666266

  • 1. [Chronic myeloproliferative diseases].
    Verh Dtsch Ges Pathol; 1983; 67():214-75. PubMed ID: 6666266
    [No Abstract] [Full Text] [Related]

  • 2. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M.
    Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract] [Full Text] [Related]

  • 3. Hematopathologic findings in the myeloproliferative disorders.
    Dickstein JI, Vardiman JW.
    Semin Oncol; 1995 Aug; 22(4):355-73. PubMed ID: 7638633
    [Abstract] [Full Text] [Related]

  • 4. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R, Marzetta K, Miglioranza A, Redaelli S, Maino C, Maffiolini A, Gorini M.
    Recenti Prog Med; 2003 Aug; 94(7-8):314-20. PubMed ID: 12868237
    [Abstract] [Full Text] [Related]

  • 5. Chronic myeloproliferative disorders with thrombocythemia: a comparative study of two classification systems (PVSG, WHO) on 839 patients.
    Thiele J, Kvasnicka HM.
    Ann Hematol; 2003 Mar; 82(3):148-52. PubMed ID: 12634946
    [Abstract] [Full Text] [Related]

  • 6. Classification of chronic myeloproliferative diseases by bone marrow biopsies. Hematological and cytogenetic findings and clinical course.
    Georgii A, Vykoupil KF, Thiele J.
    Bibl Haematol; 1984 Mar; (50):41-56. PubMed ID: 6590038
    [No Abstract] [Full Text] [Related]

  • 7. Myelofibrosis in the myeloproliferative disorders.
    Ellis JT, Peterson P.
    Prog Clin Biol Res; 1984 Mar; 154():19-42. PubMed ID: 6382293
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.
    Tefferi A.
    Semin Hematol; 1999 Jan; 36(1 Suppl 2):3-8. PubMed ID: 9930550
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders.
    Sayinalp N, Cinar H, Uner A, Haznedaroğlu IC, Büyükaşik Y, Göker H, Aksu S, Ozcebe OI, Karakuş S, Kirazli S, Dündar SV.
    Clin Lab Haematol; 2004 Aug; 26(4):265-8. PubMed ID: 15279663
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cytogenetic studies in the chronic myeloproliferative syndrome.
    Kiossoglou KA, Mitus WJ, Dameshek W.
    Blood; 1966 Aug; 28(2):241-52. PubMed ID: 5222584
    [No Abstract] [Full Text] [Related]

  • 17. Classification of myeloproliferative disorders by bone marrow histology.
    Frisch B, Bartl R, Burkhardt R, Jäger K, Mahl G, Kettner G.
    Bibl Haematol; 1984 Aug; (50):57-80. PubMed ID: 6590039
    [No Abstract] [Full Text] [Related]

  • 18. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
    Thiele J, Kvasnicka HM, Vardiman J.
    Best Pract Res Clin Haematol; 2006 Aug; 19(3):413-37. PubMed ID: 16781481
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.